Method for eliminating cancer cells

Patent number:

WO2020079243

Comunidad de Madrid.svg
No items found.

The CNIO has developed a gene-editing based cancer treatment where cancer cells are selectively eliminated. The inventors have found a novel method for eliminating cancer cells, wherein said cells comprise a genomic rearrangement which leads to genomic amplifications. The present invention provides a way to eliminate cancer cells specifically using endonuclease(s) that cleave the genome at specific sites, which results in a selective elimination of the cancer inducing gene and thereby elimination of the cancer cells.

Countries:
Spain
Regions:
Community of Madrid
Centers:
CENTRO NACIONAL DE INVESTIGACEIONES ONCOLOGICAS CNIO, SPANISH NATIONAL CANCER RESEARCH CENTRE
Other entities:
FUNDACION INSTITUTO DE INVESTIG CONTRA LA LEUCEMIA JOSEP CARRERAS
Sectors:
Health
Subsectors:
Biotechnology
TRL Level:
TRL 4 – technology validated in lab
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

The inventors have found a simple and straightforward way to design a treatment which is universal (not patient specific). For those cancers where there is a fusion gene and fusion protein, the present invention allows the truncation or the elimination of the fusion protein, which in turn leads to the death of the cancer cell. The present invention provides a therapy with minimal side effects since the modification of the coding regions of the genome will only take place in cells carrying the genomic rearrangement, i.e. in cancer cells.

Comments

Other related patents

Health

SULFATED C19 STEROID HORMONES TO TREAT AND/OR PREVENT PROTEOTOXICITY IN PROTEIN-AGGREGATION DISEASES

Countries
Spain
Know more
Health

Compounds for the treatment of neurodegenerative and/or cardiovascular diseases

Countries
Spain
Know more
Health

USE OF NAPYRADIOMYCINS WITH ANTIFOULING ACTIVITY AND THEIR COMPOSITIONS

Countries
Portugal
Know more
Get back to patents directory